News Snapshot:
The results, published on Tuesday in The Lancet Infectious Diseases Journal, add to the number of vaccine candidates under trial that have been found safe. The Chinese trial involved more than 700 volunteers recruited in China between April 16 and May 5. world Updated: Nov 18, 2020, 05:22 IST Prasun Sonwalkar Hindustan Times, London CoronaVac is a chemically-inactivated whole virus vaccine based on a strain of SARS-CoV-2 that was originally isolated from a patient in China. (AP file photo) Results from an early-phase randomised clinical trial of a Chinese vaccine candidate based on the inactivated whole SARS-CoV-2 virus (CoronaVac) show...
